CompletedNot Applicable

Real-life Clinical Experience With Ialuadapter Study

Netherlands61 participantsStarted 2023-11-01

Plain-language summary

A retrospective study from a single center was performed. Quantitative and qualitative data was obtained on the use of the syringe adapter (IALUADAPTER®) in 61 patients with IC/BPS (n=48), rUTI (n=6) and mixed /other diagnoses (including OAB; n= 7) who were receiving intravesical therapy. The evaluation period was 6 months during 2018-2019. Reasons for trying the syringe adapter, reasons for continuing with it and occurrence of UTIs before and during the evaluation period were recorded. In addition, 3 year follow-up data were obtained to assess long-term usage of the syringe adapter.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with IC/BPS, recurrent UTIs and/or OAB * Receiving intravesical instillations with a conventional single-use catheter before the syringe adapter evaluation period which took place between September 2018 and the end of February 2019 (6m). Exclusion Criteria: * Patients with a high post-void residue of \>100ml or with an indwelling catheter were excluded from the analyses. * Patients who cannot sign informed consent.

What they're measuring

Number of participants who reported success (in using syringe adapter) Yes/No

Timeframe: 6 months

Trial details

NCT IDNCT06540248

SponsorRadboud University Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-11-30

View on ClinicalTrials.gov More Interstitial Cystitis, Chronic trials